Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
Authors
Keywords
-
Journal
Frontiers in Chemistry
Volume 2, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-10-14
DOI
10.3389/fchem.2014.00087
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical Modification Study of Antisense Gapmers
- (2018) Robert Stanton et al. Nucleic Acid Therapeutics
- Development of Therapeutic Splice-Switching Oligonucleotides
- (2014) Petra Disterer et al. HUMAN GENE THERAPY
- Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model
- (2014) Burcu Bestas et al. JOURNAL OF CLINICAL INVESTIGATION
- Intracellular Fate of Spherical Nucleic Acid Nanoparticle Conjugates
- (2014) Xiaochen A. Wu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Gold Nanoparticles for Nucleic Acid Delivery
- (2014) Ya Ding et al. MOLECULAR THERAPY
- Translating chitosan to clinical delivery of nucleic acid-based drugs
- (2014) Carla Pereira Gomes et al. MRS BULLETIN
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides
- (2013) Mehrdad Dirin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy and safety of mipomersen sodium (Kynamro)
- (2013) Kees Hovingh et al. Expert Opinion On Drug Safety
- The Chemistry and Biology of Oligonucleotide Conjugates
- (2012) R. L. Juliano et al. ACCOUNTS OF CHEMICAL RESEARCH
- Delivery of molecular and cellular medicine to solid tumors
- (2012) Rakesh K. Jain ADVANCED DRUG DELIVERY REVIEWS
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer
- (2011) D. S. Hong et al. CLINICAL CANCER RESEARCH
- Silencing disease genes in the laboratory and the clinic
- (2011) Jonathan K Watts et al. JOURNAL OF PATHOLOGY
- Unlocked nucleic acid – an RNA modification with broad potential
- (2011) Anna Pasternak et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Genetic therapies for RNA mis-splicing diseases
- (2011) Suzan M. Hammond et al. TRENDS IN GENETICS
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Off-Target Effects Related to the Phosphorothioate Modification of Nucleic Acids
- (2010) Johannes Winkler et al. ChemMedChem
- Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection
- (2010) Y Zhang et al. GENE THERAPY
- Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
- (2010) Alaaldin M. Alkilany et al. JOURNAL OF NANOPARTICLE RESEARCH
- Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
- (2010) Ellen Marie Straarup et al. NUCLEIC ACIDS RESEARCH
- Antisense oligonucleotide pharmacokinetics and metabolism
- (2009) Richard S Geary Expert Opinion on Drug Metabolism & Toxicology
- A proteomic study reveals unspecific apoptosis induction and reduction of glycolytic enzymes by the phosphorothioate antisense oligonucleotide oblimersen in human melanoma cells
- (2009) Martina Stessl et al. Journal of Proteomics
- Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
- (2009) R. Juliano et al. MOLECULAR PHARMACEUTICS
- Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
- (2009) C. A. Stein et al. NUCLEIC ACIDS RESEARCH
- Nanomaterial standards for efficacy and toxicity assessment
- (2009) Pavan P. Adiseshaiah et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Accessing the therapeutic potential of immunostimulatory nucleic acids
- (2008) Winfried Barchet et al. CURRENT OPINION IN IMMUNOLOGY
- The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer
- (2008) E Wisse et al. GENE THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now